Loading clinical trials...
Loading clinical trials...
Enhancing the Anabolic Effect of Nutrition in Critically Ill Patients by Administering Exogenous Amino Acids
Enhancing the anabolic effect of nutrition in critically ill patients by administering exogenous amino acids.
Critically-ill patients admitted to the intensive care unit are invariably catabolic and are commonly undernourished. Previous observational studies indicate that increased dietary administration of protein or essential amino acids might be associated with improved clinical outcomes. The investigators propose that the parenteral supplementation of intravenous amino acids in critically-ill patients will restore anabolic processes and that anabolism is associated with molecular markers of amino acid sensing and protein synthesis. The results from this study will establish biomarkers of anabolism (i.e., nutritional success) that can be used in future clinical trials on the use of amino acid supplementation in the critically-ill.
Age
18 - No limit years
Sex
ALL
Healthy Volunteers
No
McGill University health Centre
Montreal, Quebec, Canada
Start Date
March 1, 2017
Primary Completion Date
January 28, 2026
Completion Date
February 28, 2026
Last Updated
October 6, 2025
30
ESTIMATED participants
Peptamen 1.5% via enteral
DIETARY_SUPPLEMENT
Prosol 20% IV to 1.75g/kg/day
DIETARY_SUPPLEMENT
Prosol 20% IV to 2.5g/kg/day
DIETARY_SUPPLEMENT
Lead Sponsor
Arnold Kristof
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT06154174